A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer

Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

NCT02202772 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma

NCT04586244 ·Status: TERMINATED ·Phase: PHASE2

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

NCT03058757 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

NCT03558503 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer

NCT06412874 ·Status: COMPLETED

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02657486 ·Status: COMPLETED ·Phase: NA

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

NCT04688931 ·Status: TERMINATED ·Phase: PHASE3

Cabozantinib for Advanced Urothelial Cancer

NCT01688999 ·Status: COMPLETED ·Phase: PHASE2

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

NCT06443944 ·Status: AVAILABLE

Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy

NCT06294054 ·Status: ACTIVE_NOT_RECRUITING

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

NCT06774131 ·Status: RECRUITING ·Phase: PHASE3

Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

NCT01589094 ·Status: COMPLETED ·Phase: PHASE2

Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma

NCT03534804 ·Status: COMPLETED ·Phase: PHASE2

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

NCT00191711 ·Status: COMPLETED ·Phase: PHASE2

RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects

NCT05943379 ·Status: RECRUITING ·Phase: PHASE2

Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma

NCT00461851 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

NCT03854721 ·Status: COMPLETED ·Phase: PHASE1

LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer

NCT02612194 ·Status: TERMINATED ·Phase: PHASE2

177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.

NCT06880757 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

NCT03697850 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer

NCT03809013 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

NCT02982395 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

NCT06245603 ·Status: RECRUITING ·Phase: NA

Salvage Docetaxel for Pretreated Urothelial Cancer

NCT01711112 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging

NCT06763354 ·Status: RECRUITING ·Phase: NA